Geode Capital Management’s Rennova Health, Inc. RNVA Stock Holding History

Geode Capital Management’s Portfolio RNVA Stock Details RNVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-41	Closed	-$1K	–	4097
2016 Q4	$1K	Hold	41	–	–	﹤0.01%	4034
2016 Q3	$3K	Hold	41	–	–	﹤0.01%	4027
2016 Q2	$11K	Hold	41	–	–	﹤0.01%	4045
2016 Q1	$14K	Hold	41	–	–	﹤0.01%	4075
2015 Q4	$25K	Hold	41	–	–	﹤0.01%	4081
2015 Q3	$128K	Buy	+41	New	+$112K	﹤0.01%	3825

Other funds holding RNVA

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Geode Capital Management's RNVA Position: Q1 2017 in Review

Geode Capital Management sold out of Rennova Health, Inc. (RNVA) in Q1 2017, closing a stake of 41 shares — an estimated $1K sold.

Geode Capital Management first reported a position in RNVA in Q3 2015 and held it in 6 quarters. The position peaked at $128K in Q3 2015. 9 funds tracked by Wall St. Rank hold RNVA as of Q1 2017.

Geode Capital Management reported no remaining Rennova Health, Inc. position as of Q1 2017 after selling out during the quarter.
Geode Capital Management sold 41 Rennova Health, Inc. shares in Q1 2017, an estimated $1K.
Geode Capital Management first reported a position in Rennova Health, Inc. in Q3 2015 and held it in 6 quarters.
Geode Capital Management's Rennova Health, Inc. position peaked at $128K in Q3 2015.
9 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q1 2017.

Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.